Ingenix.Aisp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-09-20
Share capital
200,000.00 PLN
Registered address
ul. Marcina Kasprzaka 4, 01-211 Warszawa, Poland
Electronic delivery address
AE:PL-41879-66005-HITVE-13
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 19 days early.
- 202501/06/2026
- 202407/07/2025
- 202311/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 288.37kMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -639.16kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 701.12kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 7.13mMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Adam Dancewicz – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Ingenix.ai Ltd | 4,000 | $54,024.85 | 100% |
The articles of association require company consent for share transfers.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2022-12-02.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $5,095,386.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 15, 2026 | Aid for research and development projects: industrial research | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Apr 15, 2026 | Aid for research and development projects: experimental development | –– | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Sep 9, 2025 | Aid in the form of wage subsidies for employing workers with disabilities | –– | Prezes Zarządu Państwowego Funduszu Rehabilitacji Osób Niepełnosprawnych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-01-01 | Using breakthrough multimodal generative artificial intelligence methods to predict clinical trial outcomes | $5.1M$5,093,307 | European Funds for a Modern Economy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Lymelab Pharmasp. z o.o. + limited partnership | $696,422.30 | lymelabpharma.com | ||
| Smart FluidS.A. | $681,963.98 | smartfluid.pl | ||
| FamicordtxS.A. | $589,673.84 | famicordtx.com | ||
| Vufinder Technologysp. z o.o. | $395,722.26 | vufinder.co | ||
| Care Access Polskasp. z o.o. | $305,248.06 | careaccess.pl | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| ETG Zamośćsp. z o.o. | $260,151.02 | etg-network.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com |
Change history
| Date | Event | |
|---|---|---|
| 2026-10-23 | Share capital increase (100,000.00 PLN → 200,000.00 PLN) | |
| 2025-11-04 | Share capital increase (5,000.00 PLN → 100,000.00 PLN) | |
| 2025-11-04 | Switch to PKD 2025 (9 PKD 2007 codes → 9 PKD 2025 codes) | |
| 2025-02-10 | Address change (Rondo Ignacego Daszyńskiego 1, 00-843, Warszawa → Ul. Marcina Kasprzaka 4, 01-211, Warszawa) | |
| 2023-11-17 | Address change (Ul. Zajęcza 15, 00-351, Warszawa → Rondo Ignacego Daszyńskiego 1, 00-843, Warszawa) |
FAQ
Last updated: 2026-10-23